Conformational changes in inter‑α‑trypsin inhibitor heavy chain 4 activate its tumor‑specific activity in mice with B16 melanoma

Kormosh,Natalya   G.; Davidova,Tatyana   V.; Kopyltsov,Vladimir   N.; Serebryakova,Marina V.; Kabieva,Aigul   O.; Voyushin,Konstantin   E.; Sitdikova,Suriya   M.; Amandzholov,Berick S.; Kiselevskii,Michail V.; Donenko,Fedor V.

doi:10.3892/mmr.2015.3961

September-2015 Volume 12 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-2015 Volume 12 Issue 3

Full Size Image

Article

Conformational changes in inter‑α‑trypsin inhibitor heavy chain 4 activate its tumor‑specific activity in mice with B16 melanoma

Authors:
- Natalya G. Kormosh
- Tatyana V. Davidova
- Vladimir N. Kopyltsov
- Marina V. Serebryakova
- Aigul O. Kabieva
- Konstantin E. Voyushin
- Suriya M. Sitdikova
- Berick S. Amandzholov
- Michail V. Kiselevskii
- Fedor V. Donenko
View Affiliations / Copyright

Affiliations: Laboratory of Cell Immunity, Institute of Diagnosis and Therapy, N.N. Blokhin Russian Cancer Research Center, Moscow 115478, Russia, Research Institute for Physical‑Chemical Medicine, Moscow 119828, Russia, Institute of Gene Biology, Russian Academy of Sciences, Moscow 117334, Russia, Kazakh Scientific Research Institute of Oncology and Radiobiology, Ministry of Health, Republic of Kazakhstan, Almaaty 480012, Kazakhstan
Pages: 4483-4493
|
Published online on: June 18, 2015

https://doi.org/10.3892/mmr.2015.3961
Expand metrics +

Abstract

It is known that blood serum proteins of tumor‑bearing mice display tumor‑specific activity. However, to date, the nature of this activity has remained elusive, and no tumor‑specific proteins have been detected in the blood serum of tumor‑bearing animals compared with those in healthy animals. The present study postulated and investigated the hypothesis that the observed tumor‑specific activity of the blood serum proteins is not associated with the appearance of novel serum proteins but with changes in the conformation of the existing ones. The present study showed conformational changes of two serum albumin proteins and inter‑α‑trypsin inhibitor heavy chain 4 (ITIH4) in mice with B16 melanoma compared to tumor‑free mice, as determined by differences in the products of proteolysis by proteomic analysis following column chromatography. The differences in the conformation of serum albumin in mice with B16 melanoma and tumor‑free mice were accompanied by a change in the interaction of these molecules with the fatty acid spin probe 16‑doxyl stearic acid. The differential conformation of ITIH4 in mice with B16 melanoma and that in tumor‑free mice was accompanied by inhibition of tumor growth and increased life span. Analysis of the role of protease‑anti‑proteases (serpins) in the serum of tumor‑bearing animals in tumor growth confirmed the hypothesis that tumor growth in the body is mediated, at least in part, via balancing of serpins.

View Figures

View References

1	Donenko FV, Ziganshin RK, Sitdikova SM, Amandzholov BS, Kiselevskii MV and Efferth T: Induction of resistance to murine tumor development is associated with alterations in the glyco-sylation of blood serum proteins. Mol Med Rep. 2:487–495. 2009.PubMed/NCBI
2	Donenko FV, Kabieva AO and Efferth T: Tumor-specific blood serum factors as determinants of tumor growth. Klin Lab Diagn. 50–52:13–15. 2013.In English, Russian.
3	Kormosh NG, Ziganshin RKh, Shender VO, Voyushin KE and Donenko FV: Changes in the serum protein composition in mice with transplanted Ehrlich's carcinoma. Bull Exp Biol Med. 158:489–492. 2015. View Article : Google Scholar : PubMed/NCBI
4	Donenko FV, Ziganshin RH, Anisimova NY, Voyushin KE, Sitdikova SM, Amandzholov BS, Kiselevskii MV and Efferth T: Identification of serpin (alpha-1-antitrypsin) as serum growth inhibitory factor in murine ehrlich carcinoma by proteomics. Cancer Genomics Proteomics. 7:147–156. 2010.PubMed/NCBI
5	Fisher B, Gunduz N, Coyle J, Rudock C and Saffer E: Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 49:1996–2001. 1989.PubMed/NCBI
6	Sitdikova SM, Amandzholov BS, Kiselevskii MV and Donenko FV: Specificity of relapses and metastases of experimental transplanted Ehrlich carcinoma and B16 melanoma. Bull Exp Biol Med. 143:80–82. 2007. View Article : Google Scholar : PubMed/NCBI
7	Kondo T: Inconvenient truth: Cancer biomarker development by using proteomics. Biochim Biophys Acta. 1844:861–865. 2014. View Article : Google Scholar
8	Sitdikova SM, Amandzholov BS, Kiselevskii MV and Donenko FV: Lectin binding to mouse blood lymphocytes during tumor growth. Bull Exp Biol Med. 140:445–448. 2005. View Article : Google Scholar
9	Donenko FV, Kabieva AO, Volkov IuT and Moroz LV: Mouse serum inhibition of cytotoxicity of goat antibodies against mouse thymocytes. Biull Eksp Biol Med. 113:642–644. 1992.In Russian. PubMed/NCBI
10	Donenko FV, Sitdikova SM, Syrtsev AV, Gradyushko AT, Kiselevsky MV, Serebryakova MV and Efferth T: Hemoglobin-associated proteins isolated from blood serum of Ehrlich carcinoma-bearing mice. Int J Oncol. 32:885–893. 2008.PubMed/NCBI
11	Sergeant K, Pinheiro C, Hausman JF, Ricardo CP and Renaut J: Taking advantage of nonspecific trypsin cleavages for the identification of seed storage proteins in cereals. J Proteome Res. 8:3182–3190. 2009. View Article : Google Scholar : PubMed/NCBI
12	Alves G and Yu YK: Improving peptide identification sensitivity in shotgun proteomics by stratification of search space. J Proteome Res. 12:2571–2581. 2013. View Article : Google Scholar : PubMed/NCBI
13	Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI and Whisstock JC: An overview of the serpin superfamily. Genome Biol. 7:2162006. View Article : Google Scholar : PubMed/NCBI
14	Goldin A, Kline I and Sofina ZP: Experimental Evaluation of Antitumor Drugs in the USA and USSR and Clinical Correlations. (National Cancer Institute Monograph 55. NIH Publication no. 1933). U.S. Department of Health and Human Services. National Institutes of Health, NCI; Bethesda, MD: 1980
15	Laemmli UK: Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
16	Gurachevsky A, Shimanovitch E, Gurachevskaya T and Muravsky V: Intra-albumin migration of bound fatty acid probed by spin label ESR. Biochem Biophys Res Commun. 360:852–856. 2007. View Article : Google Scholar : PubMed/NCBI
17	Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP and Matucci Cerinic M: Coagulation factor XIII: A multifunctional transglutaminase with clinical potential in a range of conditions. Thromb Haemost. 113:686–697. 2015. View Article : Google Scholar : PubMed/NCBI